NHS faces generic-only drug future warns AstraZeneca
The CEO of pharmaceutical giant AstraZeneca warns that UK patients may be limited to generic medicines unless the NHS increases what it pays for innovative new treatments, raising concerns about healthcare quality and medical research funding.